Oxycodon-Naloxon-Mepha 5 mg/2.5 mg
Oxycodon-Naloxon-Mepha 5 mg/2.5 mg is a medicine authorised by Swissmedic under authorisation number 65742. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 26 August 2016 and the authorisation is valid without a time limit. ATC code N02AA55 places the medicine in the group Analgesics.
| Authorisation number | 65742 |
|---|---|
| Name | Oxycodon-Naloxon-Mepha 5 mg/2.5 mg |
| Full name | Oxycodon-Naloxon-Mepha 5 mg/2.5 mg, Retardtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A+ · Prescription with conditions |
| ATC code | N02AA55 |
| First authorisation | 26 August 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Oxycodon-Naloxon-Mepha 5 mg/2.5 mg, Retardtabletten | A+ | 26 August 2016 |
| 2 | Oxycodon-Naloxon-Mepha 10 mg/5 mg, Retardtabletten | A+ | 26 August 2016 |
| 3 | Oxycodon-Naloxon-Mepha 20 mg/10 mg, Retardtabletten | A+ | 26 August 2016 |
| 4 | Oxycodon-Naloxon-Mepha 40 mg/20 mg, Retardtabletten | A+ | 26 August 2016 |
| 5 | Oxycodon-Naloxon-Mepha 30 mg/15 mg, Retardtabletten | A+ | 28 January 2019 |
| 6 | Oxycodon-Naloxon-Mepha 60 mg/30 mg, Retardtabletten | A+ | 31 July 2026 |
| 7 | Oxycodon-Naloxon-Mepha 80 mg/40 mg, Retardtabletten | A+ | 31 July 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 2 | 60 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 3 | 30 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 4 | 60 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 5 | 30 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 6 | 60 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 7 | 30 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 8 | 60 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 9 | 30 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 10 | 60 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 11 | 30 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 12 | 60 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 13 | 30 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
| 14 | 60 | Tablette(n) | N02AA55 | 01.01.3. | A+ |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Oxycodon-Naloxon-Mepha 5 mg/2.5 mg authorised in Switzerland?
Yes. Oxycodon-Naloxon-Mepha 5 mg/2.5 mg is authorised by Swissmedic under authorisation number 65742, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Oxycodon-Naloxon-Mepha 5 mg/2.5 mg have?
Oxycodon-Naloxon-Mepha 5 mg/2.5 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.
Who is the authorisation holder of Oxycodon-Naloxon-Mepha 5 mg/2.5 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.